# US 2016/0235799 A1 · Product and method of deploying kale derivatives for anti-cancer effects

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0235799 A1
- Document ID: US20160235799A1
- Status: Published application
- Kind: A1
- Application number: 15/040,667
- Filed: 2016-02-10
- Published: 2016-08-18
- Earliest claimed: 2015-02-10
- Inventors: Bilal Qizilbash; Elizabeth Brandon
- Web page: https://patentgrep.com/patent/US20160235799A1

## CPC

- A61K 36/31: Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/0095: {Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches (A61K9/0007 takes precedence; eatable gels or foams A61K9/0056; oral mucosa adhesive forms A61K9/006)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present disclosure describes chemopreventative and/or chemotherapeutic compositions for inducing apoptosis in cancer cells which include kale and methods of inducing apoptosis in cancer cells utilizing the chemopreventative and/or chemotherapeutic compositions including kale.

## Claims

### Claim 1

A method of inducing apoptosis in cancer cells comprising:
applying a chemopreventative composition comprising kale juice to cancer cells.

### Claim 2 (depends on 1)

The method of claim 1, wherein the kale of the chemopreventative composition is selected from the group consisting of curly kale, baby kale, organic kale, kale harvested during seeding time, and combinations thereof.

### Claim 3 (depends on 2)

The method of claim 2, wherein the kale of the chemopreventative composition comprises curly kale.

### Claim 4 (depends on 1)

The method of claim 1, wherein the kale juice of the chemopreventative composition is unfiltered.

### Claim 5 (depends on 1)

The method of claim 1, wherein the kale juice of the chemopreventative composition comprises freeze-thawed kale.

### Claim 6 (depends on 1)

The method of claim 1, wherein the kale juice of the chemopreventative composition comprises sonicated kale.

### Claim 7 (depends on 1)

The method of claim 1, wherein the kale juice of the chemopreventative composition comprises non-heated kale.

### Claim 8 (depends on 1)

The method of claim 1, wherein the cancer cells are selected from the group consisting of melanoma cells, breast cancer cells, colon cancer cells, ovarian cancer cells, prostate cancer cells, brain cancer cells, bone cancer cells, bladder cancer cells, testicular cancer cells, thyroid cancer cells, lung cancer cells, liver cancer cells, pancreatic cancer cells, throat cancer cells, and combination thereof.

### Claim 9 (depends on 1)

The method of claim 1, wherein the cancer cells comprise melanoma cells.

### Claim 10 (depends on 9)

The method of claim 9, wherein the step of applying the chemopreventative composition includes topical delivery of the composition.

### Claim 11 (depends on 10)

The method of claim 10, further comprising applying the chemopreventative composition to non-cancerous cells, wherein the chemopreventative composition is non-toxic to the non-cancerous cells.

### Claim 12 (depends on 11)

The method of claim 11, wherein the chemopreventative composition promotes the growth of the non-cancerous cells.

### Claim 13 (depends on 12)

The method of claim 12, wherein the non-cancerous cells are epithelial cells.

### Claim 14 (depends on 1)

The method of claim 1, further comprising maintaining interaction between the chemopreventative composition and the cancer cells for more than 7 hours.

### Claim 15 (depends on 1)

The method of claim 1, further comprising maintaining interaction between the chemopreventative composition and the cancer cells for more than 20 hours.

### Claim 16 (depends on 1)

The method of claim 1, wherein the chemopreventative composition further comprises at least one of a pharmaceutically acceptable carrier or a surfactant.

### Claim 17

A chemopreventative composition for inducing apoptosis in cancer cells comprising:
kale juice, and
at least one of a pharmaceutically acceptable carrier or a surfactant.

### Claim 18 (depends on 17)

The chemopreventative composition of claim 17, wherein the particle size ranges from about 35 microns to about 200 microns.

### Claim 19 (depends on 17)

The chemopreventative composition of claim 17, wherein the pharmaceutically acceptable carrier is selected from the group consisting of water, saline, Ringer's Lactate solutions and dextrose solution.

### Claim 20 (depends on 17)

The chemopreventative composition of claim 17, wherein the surfactant is selected from the group consisting of sodium lauryl sulfate, ammonium laureth sulfate, disodium lauryl sulfosuccinate, cocamphocarboxyglycinate, cocoamidopropyl betaine, alpha-olefin sulfonate, and combinations thereof.

### Claim 21 (depends on 17)

The chemopreventative composition of claim 17, wherein the composition is a topical solution.

### Claim 22 (depends on 21)

The chemopreventative composition of claim 21, wherein the topical solution comprises a concentration of the kale juice ranging from about 1% by wt to about 90% by wt.

### Claim 23 (depends on 21)

The chemopreventative composition of claim 21, wherein the topical solution comprises a concentration of the kale juice below 400 uL/mL.

### Claim 24 (depends on 17)

The chemopreventative composition of claim 17, wherein the composition induces apoptosis in cancer cells comprising melanoma cells.

### Claim 25 (depends on 17)

The chemopreventative composition of claim 17, wherein the chemopreventative composition is non-toxic to non-cancerous cells.

### Claim 26 (depends on 25)

The chemopreventative composition of claim 25, wherein the chemopreventative composition promotes growth of the non-cancerous cells.

### Claim 27 (depends on 26)

The chemopreventative composition of claim 26, wherein the non-cancerous cells are epithelial cells.

### Claim 28 (depends on 17)

The chemopreventative composition of claim 17, further comprising a therapeutic agent.

### Claim 29

A method of reducing cancerous or precancerous skin lesions comprising:
orally-ingesting a chemopreventative composition comprising a juiced kale solution and
repeating the step of orally-ingesting the chemopreventative composition on at least a daily basis for at least one week.
